Research programme: non-nucleoside polymerase inhibitors - Assembly Biosciences
Latest Information Update: 15 Feb 2024
At a glance
- Originator Assembly Biosciences
- Class Antivirals; Small molecules
- Mechanism of Action Polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Herpesvirus infections
Most Recent Events
- 09 Feb 2024 Early research in Herpesvirus infections in USA (unspecified route) (Assembly Biosciences pipeline, February 2024)